In the prevention of kidney disease in patients with type 2 diabetes (T2D) and mildly reduced kidney function, SGLT2 inhibitors (SGLT2i) showed a stronger benefit than GLP-1 receptor agonists (RA) and ...
Q3 2025 Earnings Call October 23, 2025 9:00 AM EDTCompany ParticipantsKristopher Doyle - Director of Investor Relations ...
United Airlines Holdings, Inc. ( NASDAQ: UAL) Q3 2025 Earnings Call October 16, 2025 10:30 AM EDT Good morning, and welcome to United Airlines Holdings' Earnings Conference Call for the Third Quarter ...
Strategic Equity Capital Plc - Final Results PR Newswire LONDON, United Kingdom, October 16 Strategic Equity Capital plc ('SEC') ...
South Korea study published in Biomarker Research of 8.4 million adults finds higher risks of overall, lung, prostate, thyroid, gastric, colorectal, and breast cancers — across both mRNA and ...
Boehringer Ingelheim today announced new data from the global Phase III FIBRONEER™ program on nerandomilast, an investigational oral preferential PDE4B inhibitor, which is currently not approved for ...
Drinking as little as one can of diet soda a day may increase the risk of nonalcohol fatty liver disease by 60%, while drinking a sugary beverage could raise the risk by 50%, a new unpublished study ...
Although the general population now has at least some immunity against COVID-19, the consequences of severe disease are frequently overlooked for certain patient populations, such as those with ...
United Airlines Holdings, Inc. (NASDAQ: UAL) released its third-quarter earnings report before Thursday’s opening bell. Below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback